New MRI scans could spot ALS earlier

NCT ID NCT04691011

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether advanced MRI scans can find new biomarkers for amyotrophic lateral sclerosis (ALS), a fast-progressing nerve disease. Researchers used high-field and very-high-field MRI to look at the brain, spinal cord, and muscles of 22 ALS patients over six months. The goal was to see if these scans could help diagnose ALS earlier and track its progression more accurately.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to better and earlier diagnosis of ALS, and help measure how the disease progresses over time.
What could go wrong
This was a small, early-stage study with only 22 participants, so results may not apply to everyone with ALS. It focused on imaging, not treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shahram Attarian

    Marseille, 13005, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.